Forget EWZ. Franklin's Brazil Twin Charges Two-Thirds Less, and It's Up 30% This Year

This is primarily a wrapper-selection trade, not a Brazil macro call. The edge is most likely to show up in fee-sensitive, benchmark-agnostic capital—RIA model portfolios, retirement accounts, and incremental allocators—while legacy holders in taxable accounts are anchored by embedded gains and may not move. That means the spread can persist longer than the headline performance differential suggests, because liquidity and inertia still justify a premium for EWZ even when the underlying basket is functionally similar.

The biggest second-order winner is VALE and, more broadly, the commodity-heavy Brazil complex: when the market is rewarding Brazil on terms of terms-of-trade strength or global reflation, the heavier materials tilt in FLBR should keep outperforming. NU is the clearest relative loser because it is the one large, high-multiple growth asset that EWZ owns and FLBR excludes; if Brazil rates stay restrictive or domestic credit growth softens, that omission can actually help FLBR by reducing duration exposure. MSCI has a small negative read-through only if the fee/structure discussion nudges new flows away from its index ecosystem, but this is more a marginal AUM/royalty concern than a fundamental threat.

The contrarian view is that the performance gap may be too small to justify churn after taxes and trading friction. EWZ’s liquidity matters in stress, and in a risk-off EM tape the ability to enter/exit with minimal slippage can overwhelm a 30-40 bps annual fee difference. The most important falsifier is a rotation back toward Brazilian domestic growth and fintech leadership: if NU and local cyclicals regain relative strength over the next 1-3 months, EWZ’s heavier exposure to the market’s more expensive growth sleeve can close the gap fast. Structurally, though, if Brazil remains a commodity-and-bank market over 6-18 months, the lower-cost basket should keep compounding the edge.